Related references
Note: Only part of the references are listed.Tumor Necrosis Factor (TNF) and Lymphotoxin-α (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
Christine F. Skibola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia
Anders Mellemgaard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Solid cancers after allogeneic hematopoietic cell transplantation
J. Douglas Rizzo et al.
BLOOD (2009)
Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Apostolia-Maria Tsimberidou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials
Liat Vidal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS
Anil K. Chaturvedi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma
Christine F. Skibola et al.
NATURE GENETICS (2009)
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia
Ola Landgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
Lindsay M. Morton et al.
BLOOD (2008)
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes:: a pooled analysis within the InterLymph consortium
Karin Ekstrom Smedby et al.
BLOOD (2008)
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the international lymphoma epidemiology consortium
Silvia De Sanjose et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice
Constantin A. Dasanu
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Inflammation in the development of lung cancer: epidemiological evidence
Eric A. Engels
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study
Stefano Sacchi et al.
HAEMATOLOGICA (2008)
Diffuse Large B-Cell Lymphoma
Jonathan W. Friedberg et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2008)
Cancer risk in people infected with human immunodeficiency virus in the United States
Eric A. Engels et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Risk of subsequent solid tumors after non-Hodgkin's lymphoma: Effect of diagnostic age and time since diagnosis
Kari Hemminki et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Temporal patterns of association between cigarette smoking and leukemia risk
David B. Richardson et al.
CANCER CAUSES & CONTROL (2008)
Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium
Anne Kricker et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Pro-posed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Lindsay M. Morton et al.
BLOOD (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Risk of second cancer after chronic lymphocytic leukemia
Claudia Schollkopf et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Risk of second malignant neoplasms among lymphoma patients with a family history of cancer
Ola Landgren et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?
Catherine Diamond et al.
CANCER CAUSES & CONTROL (2007)
Elevated risk of lung cancer among people with AIDS
Anil K. Chaturvedi et al.
AIDS (2007)
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy
Vincenzo Callea et al.
LEUKEMIA & LYMPHOMA (2006)
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
Jonathan D. Tward et al.
CANCER (2006)
Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study
NY Mudie et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Lung cancer in patients with chronic lymphocytic leukemia -: Does the HER-2 oncogene play a role?
A Musolino et al.
LUNG CANCER (2005)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples
LR Goldin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma
P Brennan et al.
BRITISH JOURNAL OF CANCER (2005)
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
P McLaughlin et al.
BLOOD (2005)
Cigarette smoking and risk of non-Hodgkin lymphoma: A pooled analysis from the international lymphoma epidemiology consortium (InterLymph)
LM Morton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Familial aggregation of Hodgkin lymphoma and related tumors
LR Goldin et al.
CANCER (2004)
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen:: a GELA cohort study on 2837 patients
M André et al.
BLOOD (2004)
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine
T Robak et al.
EUROPEAN JOURNAL OF CANCER (2004)
Population-based surveillance of HIV-associated cancers: utility of cancer registry data
CA Clarke et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland
D McKenna et al.
BRITISH JOURNAL OF CANCER (2003)
Relationship between Hodgkin's and non-Hodgkin's lymphomas
RM Amini et al.
MEDICAL ONCOLOGY (2003)
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
VA Morrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Modulating apoptosis pathways in low-grade B-Cell malignancies using biological response modifiers
JC Reed et al.
SEMINARS IN ONCOLOGY (2002)
Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment
AJ Swerdlow et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
